. Xenobiotic efflux pumps in isolated fish brain capillaries. Am J Physiol Regulatory Integrative Comp Physiol 282: R191-R198, 2002; 10.1152/ ajpregu.00305.2001.-To identify specific transporters that drive xenobiotics from the central nervous system to blood, the accumulation of fluorescent drugs was studied in isolated capillaries from killifish and dogfish shark brain using confocal microscopy and quantitative image analysis. In killifish brain capillaries, luminal accumulation of fluorescent derivatives of cyclosporin A and verapamil was concentrative, specific, and energy dependent (inhibition by KCN). Transport was reduced by PSC-833, but not by leukotriene C 4, indicating the involvement of P-glycoprotein. The ability of capillaries to transport the cyclosporin A derivative was unchanged over 20 h, demonstrating the long-term viability of the preparation. Luminal accumulation of the fluorescent organic anions sulforhodamine 101 and fluorescein-methotrexate was also concentrative, specific, and energy dependent. Transport of these compounds was reduced by leukotriene C 4, but not by PSC-833, indicating the involvement of a multidrug resistance-associated protein (Mrp). Similar results were obtained for isolated capillaries from dogfish shark. Immunostaining localized P-glycoprotein and Mrp2 to the luminal surface of the killifish brain capillary endothelium. These findings validate a new and long-lived comparative model for studying drug transport across the bloodbrain barrier and, as in mammals, implicate P-glycoprotein and Mrp2 in transport from the central nervous system to blood in fish.
THE CELLS OF THE CENTRAL NERVOUS SYSTEM (CNS) are particularly sensitive to chemical injury and, thus, require a highly regulated extracellular environment. In this regard, the brain capillary endothelium is a formidable barrier to the entry of xenobiotics into the CNS. This barrier protects the CNS from toxic chemicals but also denies entry to therapeutics. Traditionally, two elements have been considered responsible for the barrier function of this nonfenestrated endothelium: tight junctions, which form an effective seal to intercellular diffusion, and the cells themselves, which exhibit a low rate of endocytosis. On the basis of the passive permeability characteristics of the capillary endothelium, one would expect drug permeability to be primarily a simple function of lipophilicity. However, many highly lipophilic drugs permeate the blood-brain barrier poorly, suggesting additional selective elements. Consistent with this, there is a growing body of evidence indicating a role for ATP-driven drug export pumps, such as P-glycoprotein, in mammalian bloodbrain barrier function: 1) P-glycoprotein is expressed in brain capillary endothelial cells (1, (3) (4) (5) , 2) excretory drug transport in monolayer cultures of capillary endothelial cells appears to be mediated by P-glycoprotein (4, 18, 20) , and 3) xenobiotic access to the CNS is greatly increased in P-glycoprotein-knockout mice (9, 14, 15) .
A critical impediment to understanding transport function in intact brain capillaries has been the lack of suitable in vitro preparations that retain viability and allow the investigator to measure transcapillary transport of diffusible solutes. We recently developed a simple but powerful system with which to study drug transport across the capillary wall (11) consisting of freshly isolated, intact brain capillaries, fluorescent substrates, and confocal imaging (11) . We have used this system to follow bath-to-lumen transport of selected fluorescent xenobiotics in capillaries from rat and pig and found such transport to be concentrative, specific, and energy dependent. On the basis of substrate and inhibitor profiles, immunostaining, and RT-PCR experiments, P-glycoprotein and multidrug-resistant protein-2 (Mrp2) appear to be involved (11, 12) .
One important shortcoming in the use of isolated brain capillaries from mammals is limited viability (19) . In our studies with isolated mammalian brain capillaries, transport and barrier functions could be maintained for only 3-5 h (11, 12) . To circumvent this problem, we have turned to tissues from poikilotherms, which generally exhibit extended viability in vitro. All vertebrates are known to possess a functional bloodbrain barrier, although anatomic differences have been noted (2) . In all vertebrates, excluding elasmobranch fishes, the anatomic barrier is at the level of the tight junctions between endothelial cells; in elasmobranchs, at least for macromolecules, it appears to be at the level of the glia, which surround the endothelium (2). Here we used confocal imaging to show that isolated killifish and dogfish shark brain capillaries exhibit P-glycoprotein-and Mrp2-mediated transport of fluorescent xenobiotics. For both species, isolated capillaries retained transport function for an extended period of time.
MATERIALS AND METHODS
Chemicals. Fluorescein-methotrexate (FL-MTX), BODIPYivermectin and BODIPY-verapamil, and Alexa-labeled secondary antibodies were purchased from Molecular Probes (Eugene, OR). A fluorescent cyclosporin A (CSA) derivative [N-⑀-(4-nitrobenzofurazan-7-yl)-D-Lys 8 (NBD)]-CSA was synthesized as described elsewhere (16) . Verapamil, CSA, and leukotriene C 4 (LTC4) were purchased from Sigma Chemical (St. Louis, MO). Rabbit polyclonal antibodies directed against Mrp2 (k78mrp2) were obtained as described previously (21) , and C219, a polyclonal antibody directed at Pglycoprotein, was purchased from Signet Pathology Systems. All other chemicals were obtained from commercial sources at the highest purity available.
Animals and capillary isolation. Killifish (Fundulus heteroclitus) and spiny dogfish sharks (Squalus acanthias) were collected by local fisherman in the vicinity of Mount Desert Island, ME, and maintained in tanks with natural, flowing seawater at the Mount Desert Island Biological Laboratory. The animals were killed, and brains were removed to ice-cold marine teleost saline containing (in mM) 140 NaCl, 2.5 KCl, 1.5 CaCl 2, 1.0 MgCl2, 5 glucose, and 20 NaHCO3 at pH 7.8 or ice-cold elasmobranch saline containing (in mM) 270 NaCl, 4 KCl, 3 MgCl 2, 2.5 CaCl2, 8 NaHCO3, 1 KH2PO4, 0.5 Na2SO4, 5 glucose, and 350 urea at pH 7.8. Solutions were gassed with 99% O 2-1% CO2.
In preliminary experiments with brain tissue from killifish and sharks, we attempted to isolate capillaries using modified mammalian procedures, which require an initial gentle homogenization followed by density gradient centrifugation (11) . To our surprise, irrespective of how the homogenization was carried out with fish tissue, it resulted in fragmentation of the capillaries. Although we could manually dissect individual capillaries from pieces of brain, this proved to be exceedingly tedious, and we encountered difficulties in transferring the vessels. To isolate capillaries, a 1-to 2-mm cube of brain tissue was transferred to a Teflon microscopy chamber containing 1.5 ml of the appropriate gassed saline solution (see above), fluorescent substrate, and inhibitors. Under a dissecting microscope, the cube was rapidly teased with fine forceps to release capillaries and other larger structures. The capillaries adhered to the chamber floor, a 4 ϫ 4-cm glass coverslip; after dissection, chambers were gassed and covered with 60-mm culture dishes. Although this procedure does not produce a greatly enriched population of capillaries that could be used for biochemical analyses, it does dissociate the capillaries from surrounding tissue, making them accessible to microscopic imaging techniques. All experiments were carried out at room temperature (18-20°C) . We previously demonstrated that neither FL-MTX nor NBD-CSA was metabolically degraded when incubated with killifish proximal tubules for Ն1 h (7, 16) .
Confocal microscopy. Capillaries in the chamber were mounted on the stage of a Zeiss 510 or an Olympus Fluoview confocal laser scanning inverted microscope. Capillaries were viewed using a ϫ40 water immersion objective (NA 1.2). For fluorescein-or BODIPY-based dyes, we used the 488-nm line of an argon ion laser, a 510-nm dichroic filter, and a 515-nm long-pass emission filter. For sulforhodamine 101, we used the Olympus system's krypton ion laser (568 nm), a 570-nm dichroic filter, and a 590-nm long-pass emission filter. Neutral density filters and reduced laser power were employed to minimize photobleaching. With these settings and with photomultiplier gain adjusted so that the average pixel intensity in the lumens of control capillaries was 2,000-3,000 (on a scale of 0-4,095), capillary autofluorescence was undetectable.
To obtain an image, dye-loaded capillaries in the chamber were viewed under reduced, transmitted light illumination, and a single vessel with well-defined open lumen and undamaged endothelium was selected. The plane of focus was adjusted to cut through the center of the lumen, and a confocal fluorescence image of the vessel was obtained as an average of four scans. The confocal image (512 ϫ 512 ϫ 12 bits) was viewed on a high-resolution monitor and saved to disk. Fluorescence intensities were measured from stored images using a Dell Precision 610 NT workstation and Scion Image or ImageJ software, as described previously (7, 11) . We assume that fluorescence intensities provide a measure of the concentrations of the fluorescent substrates in the luminal compartment of the capillaries (for discussion of the evidence that led us to that assumption see Refs. 7, 10, and 16).
Immunohistochemistry. Brain capillaries in the appropriate physiological saline (see Animals and capillary isolation) were fixed for 10 min at room temperature in 2% (vol/vol) formaldehyde-0.1% (vol/vol) glutaraldehyde. After they were washed in saline, tubules were permeabilized in 1% (vol/vol) Triton X-100 in saline, washed, and incubated for 90 min at 37°C in saline with primary antibody: C219 for P-glycoprotein and k78mrp2 (8, 21) for Mrp2. After they were washed, capillaries were exposed to an Alexa 488-labeled secondary antibody for 60 min at 37°C. After final washing, capillaries were viewed with the Olympus Fluoview confocal laser scanning microscope, as described above.
Statistics. Values are means Ϯ SE. Means were considered to be statistically different when P Ͻ 0.05 by use of the appropriate paired or unpaired t-test. Figure 1 shows confocal and bright-field images of killifish brain capillary segments incubated in medium containing 1 M NBD-CSA, a substrate for P-glycoprotein (16) . The C-shaped capillary in the center of the field has a thin endothelium and an open lumen, characteristics common to most of the vessels isolated by dissection. Although not evident in this image, higher magnification indicated that the ends of most capillaries appeared closed, and no leakage of fluorescent drug was seen. However, some capillaries possessed open ends from which a plume of diluted dye could be observed using high magnification and increased detector sensitivity. The capillary below and to the left of the central vessel has a collapsed lumen (Fig. 1) . We estimate that, in 20-40% of isolated capillaries, lumens were totally or partially collapsed. Capillaries with collapsed lumens were not used for measurements of drug accumulation.
RESULTS
Isolated killifish brain capillary segments were 3-5 m in diameter and up to several hundred micrometers long. Pericytes are embedded within the capillary endothelium; these are evident as large, oval-shaped cells on the surface. In addition, capillary lumens contain a fluid-filled space and some blood cells, which can be recognized by their regular, ovoid shape and limiting membranes. Preliminary experiments with fluorescein-labeled dextrans (10,000-40,000 Da) indicated no penetration of the dye into the luminal space in 1-5 h (not shown), demonstrating in the isolated capillary that the endothelium presents a significant barrier to the diffusional entry of large molecules, a finding consistent with the known properties of brain capillaries in vivo. Figure 1A is a single optical slice showing a confocal section of the central capillary. NBD-CSA fills the capillary lumen, and luminal fluorescence is substantially higher than medium fluorescence. The magnitude of drug accumulation within the lumen can best be appreciated from the plot in Fig. 1D , which shows a lumen-to-medium intensity ratio of 5-6. In some parts of the vessel, it appears as though cellular fluorescence is slightly higher than luminal fluorescence, and this may reflect intracellular compartmentation of the CSA derivative. CSA is known to partition into lipids and to bind to cell proteins, e.g., cyclophylin.
The images in Fig. 1 show NBD-CSA transport in killifish capillaries ϳ1 h after isolation. Other experiments demonstrated that capillary morphology and drug transport function were preserved for Ն20 h. For example, we incubated isolated capillaries in chambers containing marine teleost saline for 0-20 h at 12°C. At 
respectively (no significant differences among means using 1-way ANOVA), indicating no loss in the ability to transport the P-glycoprotein substrate over ϳ1 day in vitro. Figure 2 shows the time course of 1 M NBD-CSA accumulation in killifish capillary lumens. Fluorescence intensities for each of four vessels are shown in Fig. 2A , and mean intensities at each time are shown in Fig. 2B . Luminal fluorescence rose rapidly and reached a steady-state value within 20 min. At that time, mean luminal fluorescence was about six times medium fluorescence, indicating uphill transport from bath to lumen. Steady-state luminal accumulation of NBD-CSA was reduced 60-70% by KCN, a metabolic inhibitor; PSC-833, a P-glycoprotein substrate and inhibitor, also substantially reduced accumulation (Fig.  3A) . CSA reduced luminal accumulation by 50%, but LTC 4 , an Mrp substrate that does not affect P-glycoprotein-mediated transport (6), was without effect. A similar inhibition pattern was found for luminal accumulation of a fluorescent derivative of verapamil, also a P-glycoprotein substrate (Fig. 3B) . None of the inhibitors tested reduced cellular accumulation of the fluorescent substrates. For example, in the experiments shown in Fig. 3A , cellular fluorescence averaged 650, 600, 632, and 685 units in control, KCN, PSC-833, and LTC 4 capillaries.
Using isolated killifish renal proximal tubules and dogfish shark rectal salt gland tubules, we previously demonstrated that the fluorescent organic anions FL-MTX and sulforhodamine 101 are substrates for Mrp2, a drug export pump that handles large organic anions and some uncharged compounds (7, 10) . Killifish brain capillaries also accumulated these compounds in their lumens. The time course of FL-MTX transport indicates that luminal accumulation was initially rapid, with vessels reaching a steady state within 45 min (Fig. 4) . Importantly, the transport inhibition pattern for FL-MTX differed from that found for the fluorescent derivatives of CSA and verapamil. FL-MTX accumulation was not reduced by PSC-833, but it was reduced by Ͼ80% by LTC 4 (Fig. 5A) . A similar differential inhibition pattern was seen when sulforhodamine 101 was the substrate (Fig. 5B) . We used antibodies to mammalian P-glycoprotein and Mrp2 to localize those transporters in killifish brain capillaries. Initial experiments in which capillaries were fixed, permeabilized, and exposed to secondary (fluorescent) but not primary antibodies showed no nonspecific labeling (not shown). In contrast, for P-glycoprotein and Mrp2, capillaries exposed to primary and secondary antibodies showed specific labeling on the luminal surface of the endothelium (Fig. 6) .
Elasmobranchs are the only vertebrates in which the anatomic blood-brain barrier for macromolecules does not coincide with tight junctions between capillary endothelial cells (2) . In elasmobranchs, studies of horseradish peroxidase penetration in vivo show that the barrier is at the level of the glial cells that surround the capillary, rather than tight junctions between endothelial cells. In initial experiments, isolated brain capillaries from dogfish shark, like killifish, clearly accumulated NBD-CSA within a luminal space (Fig. 7) .
However, in shark capillaries, the cellular layer enclosing the lumen was substantially thicker, and the barrier that prevents leakage of drug from lumen to bath could be seen to extend to the basal region of the endothelium. Irrespective of the anatomic differences, shark capillaries exhibited luminal accumulation of fluorescent derivatives of CSA, verapamil, and ivermectin, all P-glycoprotein substrates (Fig. 8) . Luminal accumulation of each of these fluorescent drug derivatives was reduced by PSC-833. Shark brain capillaries also exhibited luminal accumulation of FL-MTX that was reduced by LTC 4 and KCN (Fig. 9) . Thus, at the functional level, shark brain capillaries appear to be similar to killifish brain capillaries.
DISCUSSION
We recently described a new approach to studying excretory (CNS-to-blood) and barrier transport func- tion in freshly isolated, intact mammalian brain capillaries. We used fluorescent substrates, confocal microscopy, and quantitative image analysis to demonstrate that the drug export pumps P-glycoprotein and Mrp2 were specific and potent components of the blood-brain barrier (11) . The primary advantage of this approach is one of spatial resolution. With the use of the optical sectioning capabilities of confocal optics, drug accumulation in the lumens of intact capillaries can be measured and the effects of specific inhibitors, neurotoxins, and regulatory molecules can be assessed. The major problem with the approach was the limited viability of mammalian capillaries; by our functional criteria, brain capillaries isolated from rat and pig retain robust drug transport for only a few hours. In the present study, we have taken a comparative approach to the problem of viability, shifting our attention to poikilotherms. We isolated brain capillaries from two species of fish, a teleost and an elasmobranch, and demonstrated transport function similar to that of mammals as well as greatly extended vessel viability.
Micrographs of brain capillary segments isolated from killifish and shark showed them to be several hundred micrometers long with an open luminal space. Although the ends of some segments appeared to be open to the medium and, thus, can be potential sites of diffusional leakage, we expect this leakage was minimized by the long diffusion distances involved and the narrow and unstirred luminal compartment. Our experiments showing exclusion of fluorescent dextrans from the lumen and long-term, concentrative, luminal accumulation of fluorescent drug derivatives support this supposition.
As in our previous study with capillaries from pig and rat (11), killifish and dogfish shark brain capillaries exhibited luminal accumulation of several fluorescent drug derivatives, including NBD-CSA, BODIPYverapamil, FL-MTX, and sulforhodamine 101 (present study). For these compounds lumen-to-medium fluorescence ratios greatly exceeded unity, indicating concentrative transport. Consistent with such transport being driven by cellular metabolism, KCN substantially reduced luminal accumulation of all compounds tested. However, neither KCN nor any of the xenobiotics tested reduced luminal accumulation by Ͼ80%. It is not clear whether this residual accumulation is a result of the experimental protocol, i.e., transport of lipophilic substrates from an infinite bath, or of modest alterations in the permeability of capillaries to small molecules caused by isolation.
Xenobiotic transport patterns in killifish and shark brain capillaries (present study) were similar to those found previously for rat and pig capillaries (11) . In fish capillaries, luminal accumulation of NBD-CSA and a fluorescent verapamil derivative was reduced by the P-glycoprotein substrates and modifiers PSC-833 and CSA, but not by LTC 4 , an inhibitor of transport mediated by Mrp but not P-glycoprotein (6) . These results indicate that P-glycoprotein participates in xenobiotic transport across the capillary endothelium. On the basis of these results, the simplest transport model would place P-glycoprotein on the luminal membrane of the endothelial cells, in the correct location to utilize ATP to pump xenobiotics from cell to blood and to act as a barrier, preventing entry into the CNS. As in studies with mammalian tissue (11, 12, 17) , the present immunostaining experiments with killifish capillaries support this luminal placement.
In contrast to the P-glycoprotein substrates, luminal accumulation of the fluorescent organic anions sulforhodamine 101 and FL-MTX was not reduced by 10 M PSC-833. At this concentration, PSC-833 would be expected to block transport mediated by P-glycoprotein. Luminal accumulation of sulforhodamine 101 and FL-MTX was, however, reduced by low concentrations of LTC 4 . This is similar to the transport and inhibition pattern for these fluorescent organic anions seen in teleost renal proximal tubule, shark rectal salt gland, and mammalian brain capillaries. In those tissues, cell-to-lumen transport of FL-MTX was attributed to Mrp2 (8) (9) (10) (11) , an Mrp isoform that is known to be highly expressed in luminal membrane of those tissues (8, 10, 11, 13) . Consistent with this finding, killifish brain capillaries immunostained with an antibody against mammalian Mrp2 showed clear-cut luminal localization of the transporter (present study).
In elasmobranchs, the blood-brain barrier for macromolecules, e.g., horseradish peroxidase, resides at the level of the glia, rather than the capillary endothelium (reviewed in Ref. 2) . On the basis of these ultrastructural findings, one might expect to find substantial differences in transport between capillaries isolated from elasmobranchs and those from other vertebrates. However, at the light-microscopic level, this does not appear to be the case. Confocal imaging experiments with brain capillaries isolated from shark show transport characteristics for fluorescent xenobiotics (present study) and fluorescent dextrans (unpublished data) similar to those found in killifish and rat and pig (11) . The primary difference between capillaries isolated from shark and those from killifish and mammals is that shark capillaries appear to retain a layer of tissue not seen in capillaries isolated from the other species. This may, indeed, constitute a glial sheath with tight junctions, but additional functional and ultrastructural studies are needed before this can be established.
Perspectives
It is becoming increasingly clear that the brain capillary endothelium is not just a passive, structural barrier that prevents entry of foreign chemicals to the CNS. Rather, brain capillary endothelial cells express several multifunctional xenobiotic transporters, including P-glycoprotein and Mrp2 (11, 12 ; present study), that can remove potentially toxic chemicals from the CNS and block xenobiotic entry from the blood. These transporters exhibit remarkably broad specificity limits. As a result, they mediate excretion (brain to blood) of metabolites and contribute to the exclusion of therapeutics as well as of toxic chemicals. To understand barrier function in intact capillaries and to devise ways that the barrier might be strengthened or circumvented, we need in vitro systems that mirror in vivo function and are robust enough to survive extended manipulation and study. On the basis of functional similarities to mammalian brain capillaries and extended viability, isolated killifish brain capillaries appear to be a promising long-lived, comparative model.
